Resilience (biotech company)

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology
gptkbp:acquiredBy	gptkb:Brammer_Bio_manufacturing_facility_(Boston) gptkb:Ology_Bioservices gptkb:Sanofi’s_manufacturing_facility_(Boston)
gptkbp:alsoKnownAs	gptkb:National_Resilience,_Inc.
gptkbp:CEO	gptkb:Rahul_Singhvi
gptkbp:focusesOn	vaccines gene therapy nucleic acids biopharmaceutical manufacturing
gptkbp:foundedIn	2020
gptkbp:founder	gptkb:Rahul_Singhvi
gptkbp:headquartersLocation	gptkb:San_Diego,_California,_United_States
https://www.w3.org/2000/01/rdf-schema#label	Resilience (biotech company)
gptkbp:industry	gptkb:biotechnology
gptkbp:mission	to build a more resilient biopharmaceutical supply chain
gptkbp:notableInvestment	gptkb:NEA_(New_Enterprise_Associates) gptkb:Flagship_Pioneering gptkb:ARCH_Venture_Partners GV (formerly Google Ventures)
gptkbp:operates	gptkb:Boston,_Massachusetts gptkb:Toronto,_Canada gptkb:San_Diego,_California gptkb:Alachua,_Florida
gptkbp:partner	gptkb:Harvard_University gptkb:Mayo_Clinic gptkb:The_University_of_Texas_MD_Anderson_Cancer_Center gptkb:Children’s_Hospital_of_Philadelphia gptkb:Harvard’s_Wyss_Institute
gptkbp:raisedCapital	over $800 million (as of 2021)
gptkbp:website	https://resilience.com/
gptkbp:bfsParent	gptkb:Lynda_Chin
gptkbp:bfsLayer	6